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The lectins DC-SIGN and DC-SIGNR augment infection by human immunodeficiency virus (HIV), Ebolavirus (EBOV) and other pathogens.
The neck domain of these proteins drives multimerization, which is believed to be required for efficient recognition of multivalent ligands. The
neck domain of DC-SIGN consists of seven sequence repeats with rare variations. In contrast, the DC-SIGNR neck domain is polymorphic and, in
addition to the wild type (wt) allele with seven repeat units, allelic forms with five and six sequence repeats are frequently found. A potential
association of the DC-SIGNR genotype and risk of HIV-1 infection is currently under debate. Therefore, we investigated if DC-SIGNR alleles
with five and six repeat units exhibit defects in pathogen capture. Here, we show that wt DC-SIGNR and patient derived alleles with five and six
repeats bind viral glycoproteins, augment viral infection and tetramerize with comparable efficiency. Moreover, coexpression of wt DC-SIGNR
and alleles with five repeats did not decrease the interaction with pathogens compared to expression of each allele alone, suggesting that potential
formation of hetero-oligomers does not appreciably reduce pathogen binding, at least under conditions of high expression. Thus, our results do not
provide evidence for diminished pathogen capture by DC-SIGNR alleles with five and six repeat units. Albeit, we cannot exclude that subtle, but
in vivo relevant differences remained undetected, our analysis suggests that indirect mechanisms could account for the association of
polymorphisms in the DC-SIGNR neck region with reduced risk of HIV-1 infection.
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The C-type (i.e. calcium dependent) lectin DC-SIGN is
expressed on dendritic cells (DCs) (Geijtenbeek et al., 2000b,
2000c) and certain types of macrophages (Granelli-Piperno et
al., 2005; Soilleux et al., 2001, 2002a). It plays a role in the
establishment of cell–cell contact (Geijtenbeek et al., 2000a,
2000c) and in the recognition and uptake of antigens (Engering
et al., 2002; Moris et al., 2004), albeit the former function has0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to this work.recently been challenged (Snyder et al., 2005b). Antigens taken
up by DC-SIGN can be processed for major histocompatibility
complex (MHC)-mediated presentation (Engering et al., 2002;
Moris et al., 2004). However, it has been proposed that a
variety of viral and non-viral pathogens evade degradation
upon DC-SIGN binding and employ this lectin to target DCs,
thereby facilitating their dissemination in the infected host (van
kooyk and Geijtenbeek, 2003). Maybe most strikingly, HIV
engages DC-SIGN on DCs to promote its spread to adjacent
susceptible cells and possibly its transport into lymphoid tissue
(Geijtenbeek et al., 2000b), a process that might be of
particular relevance during the early phase of HIV infection.
The DC-SIGN related lectin DC-SIGNR (also termed L-
SIGN) shares 77% amino acid identity with DC-SIGN and is6) 354 – 363
www.e
Fig. 1. Schematic representation of the DC-SIGNR alleles analyzed. The neck
domain of wt DC-SIGNR contains seven and a half repeat units (RU). Each
repeat unit can be subdivided into two sequence blocks, indicated in grey and
white. The allele F10 is wt, while allele 125 contains six and alleles C57 and
1411 contain five repeat units, respectively.
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and in cells lining placental capillaries (Bashirova et al., 2001;
Mummidi et al., 2001; Soilleux et al., 2002b; Po¨hlmann et al.,
2001c). DC-SIGNR interacts with the same spectrum of
pathogens as DC-SIGN and might particularly promote spread
of viruses that target liver and lymph nodes (Baribaud et al.,
2002a). For example, binding to DC-SIGNR increases Ebola-
virus (EBOV) infectivity (Alvarez et al., 2002; Simmons et al.,
2003) and might augment EBOV entry into cells lining the
sinusoids in lymph node and liver, which are major targets at the
later stages of EBOV infection (Geisbert et al., 2003a, 2003b).
DC-SIGNR might also enhance HIV infection of liver
sinusoidal endothelial cells (LSECs), which are permissive
(Steffan et al., 1992) and might constantly release progeny
virions into the blood stream. Moreover, DC-SIGNR on LSECs
might concentrate hepatitis C virus in the liver and might
promote trans-infection of adjacent hepatocytes (Cormier et al.,
2004; Gardner et al., 2003; Lozach et al., 2003, 2004; Ludwig et
al., 2004; Po¨hlmann et al., 2003). Thus, DC-SIGN and DC-
SIGNR (collectively referred to as DC-SIGN/R) could facilitate
infection by several clinically relevant pathogens and constitute
potential targets for therapeutic intervention.
DC-SIGN/R exhibit a comparable domain organization. The
N-terminal domain is located in the cytoplasm and is followed
by a transmembrane domain, which anchors the proteins in the
cytoplasmic membrane. The extracellular domain consists of a
short unique domain, a neck region formed by seven complete
and one incomplete repeat of a 23 amino acid sequence and a
carbohydrate recognition domain (CRD). While the CRD
complexes carbohydrates of the high-mannose type (both
DC-SIGN and DC-SIGNR) and fucose containing ligands
(only DC-SIGN) (Feinberg et al., 2001; Guo et al., 2004), the
neck region is essential for lectin tetramerization (Feinberg et
al., 2005; Mitchell et al., 2001; Snyder et al., 2005a, 2005b).
Formation of DC-SIGN/R tetramers is believed to be important
for high-affinity binding to multivalent ligands (Bernhard et al.,
2004; Feinberg et al., 2005; Mitchell et al., 2001; Snyder et al.,
2005a, 2005b). The neck region of DC-SIGN usually
comprises seven repeats, although rare exceptions have been
identified (Liu et al., 2004). In contrast, the neck region of DC-
SIGNR is polymorphic and can harbor between three to nine
repeat units (Bashirova et al., 2001; Mummidi et al., 2001).
The DC-SIGNR allele with seven repeat units is most common
among Caucasians (54%) and is thus considered wild type (wt),
followed by the alleles with five and six repeat units, which
were detected in 29% and 12%, respectively, of the individuals
analyzed in one study (Bashirova et al., 2001). Individuals can
be heterozygous or homozygous for these DC-SIGNR alleles,
in fact, subjects homozygous for wt DC-SIGNR or the allele
harboring five repeat units are frequently found (29% and 16%,
respectively, of individuals analyzed in one report; Lichterfeld
et al., 2003). The number of repeat units can determine the
lectin multimerization status (Feinberg et al., 2005; Snyder et
al., 2005b) and the risk for HIV-1 infection (Liu et al., 2004, in
press), albeit the latter finding is controversial (Lichterfeld et
al., 2003). However, it is unknown if alleles with less than
seven repeat units exhibit alterations in pathogen binding.Here, we investigated if patient derived DC-SIGNR alleles
with five and six repeat units augment infection by HIV-1 and
by HIV-pseudotypes bearing the envelope glycoprotein of
EBOV and the spike (S) protein of SARS-coronavirus (CoV).
We report that DC-SIGNR alleles with five, six or seven repeat
units bind to viral glycoproteins, enhance viral infection and
form tetramers with comparable efficiency, indicating that the
absence of two repeat units does not appreciably compromise
DC-SIGNR interaction with pathogens. Also, coexpression of
alleles with seven and five repeat units augmented viral
infectivity to levels observed upon expression of each allele
alone, suggesting that under conditions of robust lectin
expression the potential formation of hetero-oligomers might
not reduce pathogen engagement substantially.
Results
DC-SIGNR alleles with five and six repeat units are efficiently
expressed at the cell surface and bind to viral glycoproteins
DC-SIGNR alleles with less than seven repeat units are
frequently found in Caucasians (Bashirova et al., 2001);
however, it is unclear if such alleles exhibit defects in pathogen
binding. To address this question, we functionally analyzed
published DC-SIGN/R constructs (Po¨hlmann et al., 2001a,
2001c) containing seven repeat units and patient derived DC-
SIGNR alleles harboring five, six and seven repeat units (Liu et
al., 2005, in press) (Fig. 1). Except of the differences in the
neck region, the DC-SIGNR variants analyzed exhibited
identical amino acid sequences. We first investigated the
importance of the number of repeat units in the DC-SIGNR
neck region for lectin expression. Therefore, the lectin variants
were transiently expressed in 293T cells and lectin expression
was analyzed by FACS (Fig. 2). All lectins were expressed at
the cell surface efficiently and to comparable degrees,
indicating that the presence of five or six repeat units does
not compromise DC-SIGNR expression.
We next assessed if the DC-SIGNR variants bind to the
glycoproteins of EBOV, SARS-CoV and HIV-1, all known
Fig. 2. DC-SIGNR alleles with five and six repeat units are efficiently expressed at the cell surface. Published wt DC-SIGN and the indicated patient derived DC-
SIGNR alleles were transiently expressed in 293T cells and surface expression analyzed by FACS using a DC-SIGN/DC-SIGNR-crossreactive monoclonal antibody.
The black-filled histograms indicate staining of control cells, the white-filled histograms show staining of lectin expressing cells. Similar results were obtained in two
independent experiments.
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proteins were employed in which the GP1 subunit of the EBOV
glycoprotein, the S1 unit of the SARS-CoV-S protein or the
gp120 subunit of the HIV-1 envelope protein were fused to the
Fc portion of human immunoglobulin. These proteins, but not
the corresponding immunoglobulin control protein, bound
efficiently and to similar levels to cells expressing the DC-
SIGNR variants, while no appreciable binding to control
transfected cells was measured (Figs. 3A, B). Thus, the allelic
DC-SIGNR forms with five and six repeat units are capable of
complexing viral glycoproteins.
Wild type DC-SIGNR and DC-SIGNR alleles with five and six
repeat units show comparable augmentation of infection in cis
and in trans
Since binding to viral glycoproteins must not necessarily
lead to augmentation of infection (Baribaud et al., 2001;
Po¨hlmann et al., 2001b), we assessed if DC-SIGNR variants
with variable repeat regions facilitate HIV transmission and
promote infection by lentiviral reporter viruses pseudotyped
with filovirus glycoproteins or SARS-CoV-S (so-called
pseudotypes). These studies were again carried out with
transiently transfected 293T cells. The 293T cell line lacks
CD4 and is not permissive to HIV-1 infection; however,
upon expression of DC-SIGN/R, these cells can bind and
transfer virus to adjoining T cells (Po¨hlmann et al., 2001c), a
process termed infection in trans. Conversely, 293T cells are
susceptible to pseudotypes bearing filovirus glycoproteins or
SARS-CoV-S and infection is enhanced in the presence of
DC-SIGN/R (Marzi et al., 2004), a process termed augmen-
tation of infection in cis. To examine enhancement of
infection in cis, the indicated lectins were transiently
transfected into 293T cells and the cells inoculated withinfectivity normalized luciferase reporter viruses bearing the
glycoproteins of EBOV, Marburgvirus (MARV) or the S
protein of SARS-CoV. In this experimental system, luciferase
is only expressed upon successful membrane fusion, reverse
transcription and integration of the proviral genome into the
cellular chromosome. In agreement with previous results
(Alvarez et al., 2002; Marzi et al., 2004; Simmons et al.,
2003; Yang et al., 2004), expression of DC-SIGN/R
enhanced filovirus glycoprotein and SARS-CoV-S dependent
entry, but had no appreciable effect on infection driven by
the glycoprotein of vesicular stomatitis virus (VSV-G) (Fig.
4A). Expression of all DC-SIGNR neck domain variants
increased infectious entry to levels observed upon expression
of the wt proteins (Fig. 4A), indicating that the presence of
five repeat units in the neck region is sufficient for
augmentation of infection in cis. To analyze lectin dependent
infection in trans, 293T cells transiently expressing the
indicated lectins were pulsed with HIV-1 NL4-3, washed and
cocultivated with CEMx174 5.25 reporter T cells. Similarly
to the results obtained upon infection with pseudotypes, wt
DC-SIGN/R and all DC-SIGNR variants examined promoted
trans infection with comparable efficiency (Fig. 4B),
suggesting that the variations in the DC-SIGNR neck region
analyzed do not affect the interaction with HIV-1.
DC-SIGNR alleles with five and six repeat units multimerize
Considering the efficient augmentation of infection in cis
and in trans, we hypothesized that the DC-SIGNR neck
region variants were still capable of multimerization. To
investigate this, lysates of transiently transfected 293T cells
were prepared under reducing and non-reducing conditions
and analyzed by SDS gel-electrophoresis followed by
Western blot analysis for DC-SIGNR expression (Fig. 5).
Fig. 3. DC-SIGNR alleles with variations in the repeat region bind viral glycoproteins. (A) The indicated DC-SIGNR alleles or empty vector were transiently
transfected into 293T cells and the cells incubated with concentrated supernatants containing comparable amounts of the indicated glycoproteins fused to the Fc
portion of human immunoglobulin or the Fc portion of human immunoglobulin alone. Glycoprotein binding was analyzed by FACS. The grey-filled histograms
indicate staining of control transfected cells, the black lines show staining of lectin expressing cells. Similar results were obtained in an independent experiment. Ig,
Immunoglobulin. (B) The geometric mean channel fluorescence values measured in panel A are shown. An independent experiment yielded similar results.
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the molecular weight of monomers, dimers, trimers and
tetramers were observed for all lectins analyzed. Similar
results were obtained when iodoacetamide was added before
harvesting cells, indicating that multimer formation was not
due to unspecific formation of disulfide bonds during
preparation of cell lysates (data not shown). Thus, the loss
of two repeat units does not compromise DC-SIGNR
multimerization.Coexpression of wt DC-SIGNR and allelic forms with five
repeat sequences does not alter augmentation of viral infection
compared to expression of each DC-SIGNR form alone
While DC-SIGNR variants with five repeat units augmented
viral infection as efficiently as the wt DC-SIGNR, it is
conceivable that coexpression of wt and allelic DC-SIGNR
leads to formation of non-functional hetero-oligomers and
thereby to reduced enhancement of viral infectivity. To address
Fig. 4. Wild type DC-SIGNR and DC-SIGNR alleles with five and six repeat
units augment viral infectivity with comparable efficiency. (A) Enhancement of
filovirus glycoprotein and SARS-CoV-S dependent infection. The indicated
lectins were transiently expressed on 293T cells, the cells infected with
lentiviral reporter viruses bearing the indicated glycoproteins and luciferase
activities in cellular lysates determined. The results of a representative
experiment performed in quadruplicates are shown, error bars indicate standard
deviation (SD). Similar results were obtained in two independent experiments.
(B) Augmentation of HIV infection. The indicated lectins were transiently
expressed on 293T cells, the cells pulsed with replication competent HIV-1
reporter virus, washed, cocultivated with CEMx174 5.25 target cells and
luciferase activities in the cocultures determined. The results of a representative
experiment carried out in quadruplicates are shown and were confirmed in two
independent experiments. Error bars indicate SD.
Fig. 5. DC-SIGNR alleles with five or six repeat units multimerize. The DC
SIGNR alleles were transiently expressed in 293T cells, the cells lysed unde
non-reducing and reducing conditions, the lysates separated by SDS-gelelec
trophoresis and lectin expression detected by Western blot. The results were
confirmed in two independent experiments. Lane 1, 7RU (F10); lane 2, 6RU
(125); lane 3, 5RU (C57); lane 4, 5RU (1411), lane 5, control. The arrows
indicate bands of the size expected for DC-SIGNR multimers.
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DC-SIGNR alleles with five repeat units or cotransfected cells
with both wt and allelic DC-SIGNR in combination, and
analyzed enhancement of EBOV glycoprotein driven infection
and HIV-1 transfer to susceptible cells. Coexpression of DC-
SIGNR with five and seven repeat units enhanced EBOV
glycoprotein but not VSV-G dependent infection to similar
levels as expression of each lectin alone (Fig. 6A). Similarly,
cells coexpressing DC-SIGNR variants with five and seven
repeat units transferred HIV to T cells as efficiently as cells
expressing each lectin variant alone (Fig. 6B). Thus, coexpres-
sion of DC-SIGNR repeat variants might not lead to reducedinteraction with pathogens, at least when cells are examined
that express high levels of the lectins.
Discussion
Here, we show that DC-SIGNR alleles with five or six
repeat units in the neck domain are expressed efficiently and
augment viral infection similarly to wt DC-SIGNR, which
contains seven repeat units. Moreover, coexpression of high
levels of wt DC-SIGNR and allelic forms with five repeat units
did not diminish augmentation of infection compared to cells
expressing either lectin alone. While it is possible that minor
but in vivo relevant differences between wt DC-SIGNR and the
DC-SIGNR alleles tested were not detected in our experimental
systems, our results do not hint towards a substantial defect of
DC-SIGNR repeat region variants in pathogen capture.
Therefore, indirect mechanisms might account, at least in part,
for an association of these alleles with reduced risk of HIV-1
infection (Liu et al., 2004, in press).
The CRD domains of DC-SIGN/R recognize high-man-
nose carbohydrates on pathogens and are essential for
pathogen binding (Feinberg et al., 2001; Guo et al., 2004;
Po¨hlmann et al., 2001a). The DC-SIGN/R neck domains form
a stalk that projects the CRDs away from the cell surface
(Feinberg et al., 2005; Guo et al., 2004; Snyder et al., 2005a).
The neck domains are composed of repeat units, which
contain helical regions (Feinberg et al., 2005). Lateral
interactions between helices in the neck domains of different
DC-SIGN/R molecules promote tetramerization (Feinberg et
al., 2005), a process thought to be important for efficient
binding to ligands displaying a high density of high-mannose
glycans on the surface (Bernhard et al., 2004; Feinberg et al.,
2005; Mitchell et al., 2001; Snyder et al., 2005b). It has been
suggested that the N- and C-terminal repeat units of the DC-
SIGN/R stalks might be particularly important for lectin
multimerization (Feinberg et al., 2005). Consistent with these
results, the patient derived DC-SIGNR alleles examined here
exhibited deletions of internal repeats and were competent to-
r
-
Fig. 6. Coexpression of wt DC-SIGNR and DC-SIGNR alleles with five repeat units does not diminish augmentation of viral infectivity. (A) Augmentation of
EBOV-GP dependent infection. The indicated lectins were transiently expressed on 293T cells, the cells infected with lentiviral reporter viruses bearing the indicated
glycoproteins and luciferase activities in cell lysates determined. The results of a representative experiment performed in quadruplicates are shown, similar results
were obtained in two independent experiments. Error bars indicate SD. (B) Augmentation of HIV-1 transfer. The indicated lectins were transiently expressed on 293T
cells, the cells incubated with replication competent HIV-1 NL4-3 reporter virus, washed and cocultivated with CEMx174 5.25 target cells and luciferase activities in
the cocultures determined. The average of six independent experiments performed with two separate plasmid preparations are shown. Error bars indicate standard
error of the mean.
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repeat units three and four or four and five does not interfere
with DC-SIGNR oligomerization.
While variation in the DC-SIGN neck region is rare (Liu et
al., 2004), DC-SIGNR alleles with five and six repeat units are
frequently found, and both homozygous and heterozygous
carriers have been identified (Bashirova et al., 2001; Lichter-
feld et al., 2003; Liu et al., 2005, in press). At present, it is
unclear, however, if the distribution of DC-SIGNR alleles
differs between ethnic groups and if endogenous expression of
these alleles on sinusoidal endothelial cells in liver and lymph
node alters cellular functions or the interaction with pathogens.
Our observation that the wt form of DC-SIGNR and DC-
SIGNR alleles with five or six repeat units equally augment
infectivity of HIV-1 and HIV-1 based pseudotypes bearing
SARS-CoV-S or EBOV-GP, indicates that homozygosity for
these alleles might not be beneficial against infection with
viruses targeting DC-SIGNR.
It has been suggested, however, that coexpression of wt
DC-SIGNR and allelic forms in cells of heterozygous carriers
might result in formation of non-functional hetero-oligomers
and thus in reduced expression of functional DC-SIGNR on
the cell surface (Feinberg et al., 2005; Koppel et al., 2005).
Since DC-SIGN dependent augmentation of infectivity
strongly depends on the level of surface expression (Po¨hl-
mann et al., 2001a), cells with reduced DC-SIGN/R expression
might be less competent to augment infectivity and might
confer some protection against infection with viruses that
engage DC-SIGN/R. Indeed, a recent study on polymorphisms
in the DC-SIGN promoter found a strong association between
mutations that reduce DC-SIGN expression and protection
against dengue fever (Sakuntabhai et al., 2005). Similarly,
certain polymorphisms in the DC-SIGN promoter were
reported to be associated with reduced risk of parenterally
acquired HIV-1 infection (Martin et al., 2004), highlighting theimportance of DC-SIGN expression levels for the efficient
interaction with pathogens.
Under the experimental conditions employed, cells coex-
pressing wt DC-SIGNR and DC-SIGNR alleles with five
repeat units were equally competent to augment infectivity as
cells expressing each lectin alone. These observations can be
explained in three ways. First, formation of hetero-oligomers
might be inefficient, second, hetero-oligomers might be
functional or third, under the conditions employed, expression
levels were still saturating even after the formation of hetero-
oligomers. Importantly, however, transfected 293T cells and
monocyte derived DCs express roughly comparable amounts of
DC-SIGN (Baribaud et al., 2002b; Po¨hlmann et al., 2001a),
and robust expression of DC-SIGNR on primary LSECs has
been demonstrated (Bashirova et al., 2001). Thus, the
experimental system employed to study the effects of coex-
pression of DC-SIGNR alleles on pathogen interactions might
reflect the in vivo situation with virus exposed cells that
express high amounts of DC-SIGNR. Such cells would be
competent to bind pathogens in a lectin dependent manner and
would not hamper dissemination of viruses that engage this
lectin. However, low levels of DC-SIGNR might be expressed
by cells at mucosal transmission sites (Liu et al., 2005) and
might contribute to capture of sexually transmitted HIV-1.
Under such circumstances, subtle differences in HIV-1 binding
by mucosal cells from individuals homo- or heterozygous for
wt DC-SIGNR might have profound impact on the establish-
ment of HIV-1 infection, particularly if one assumes that HIV-1
completes several rounds of replication in the mucosal tissue
during which these differences could be amplified.
It has been reported that variations in the DC-SIGNR neck
domain are not associated with protection against HIV-1
infection or with slow progression to AIDS (Lichterfeld et
al., 2003). In contrast, a different study found that homozy-
gosity for wt DC-SIGNR is associated with increased risk for
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seven/five repeat units genotype) seems to confer relative
protection (Liu et al., in press). A likely explanation for this
discrepancy are differences in the study populations, with the
first study lacking a highly exposed seronegative cohort, a key
group for such an analysis. In any case, it still needs to be
determined if HIV-1 engages DC-SIGNR on endothelial cells
of liver and lymph node sinusoids and if DC-SIGNR dependent
binding to these cells augments viral infectivity. The observa-
tions that cultured LSECs express high levels of DC-SIGNR
and are permissive to HIV-1 infection (Steffan et al., 1992) and
that alternative DC-SIGNR transcripts are frequently found in
genital mucosa (Liu et al., 2005) are in agreement with a role of
DC-SIGNR in HIV-1 dissemination. An association between
polymorphisms in the neck region and susceptibility to HIV-1
infection has also been documented for DC-SIGN (Liu et al.,
2004); however, the number of individuals displaying such
polymorphisms was low. Nevertheless, it will be interesting to
investigate if DCs from these individuals show a reduced
ability to transmit HIV-1.
In summary, we found no evidence that DC-SIGNR alleles
with five or six repeat units show substantial defects in the
interaction with viruses or that cells coexpressing high amounts
of these alleles together with wt DC-SIGNR are less competent
to augment viral infectivity compared to cells expressing wt
DC-SIGNR alone. While these results do not support a
beneficial role of DC-SIGNR alleles with less than seven
repeat units in viral infection, it is possible that these alleles are
in linkage disequilibrium with other polymorphisms, such as
regulatory or structural polymorphisms in the DC-SIGNR and
DC-SIGN genes, which could explain a protective effect
against viral infection. Moreover, it cannot be excluded that
we did not detect subtle effects that might nevertheless be
relevant in vivo, particularly when being amplified during
multiple rounds of viral replication. Finally, further studies
need to determine whether the rarely found alleles with three,
four, eight or nine repeat units are less adept in binding
pathogens than the wt protein and whether these alleles are
associated with relative protection against infection by HIV-1
and other viruses.
Material and methods
Cell culture
293T cells were propagated in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), penicillin and streptomycin. CEMx174 5.25 (Hsu et al.,
2003) cells were maintained in RPMI 1640 containing 10%
FBS, penicillin and streptomycin. All cells were grown at 37
-C and 5% CO2.
Plasmid construction
To generate vectors for expression of different DC-SIGNR
isoforms, total RNA was extracted from monocyte derived
DCs by Qiagen RNeasy Protect Kit (Qiagen, Valencia, CA)(Liu et al., 2005). Fragments spanning the entire DC-SIGNR
coding region were reverse transcribed (RT) and then
amplified by nested PCR as described (Liu et al., 2005).
Specifically, the following primers were used: RT primer RR:
5V-GACGTTACAACATTTACCACTT-3V; first PCR primers
RR and RF: 5V-AACATCTGGGGACAGCG-3V (Soilleux et
al., 2000); second PCR primers RcR: 5V-AGGCTAGCAGG-
GAAACAACT-3V and RcF: 5V-TGGGGACAGCGGGAAAA-
CAT-3V. For expression of soluble EBOV subtype Zaire
glycoprotein (GP), the GP1 encoding part of the open reading
frame (ORF) was fused to the Fc part of human IgG1 via
PCR and cloned in frame with the amino-terminal murine IgG
kappa signal peptide in the eukaryotic expression vector
pAB61 (Birkmann et al., 2001). The same strategy was
employed to generate an HIV-1 Env-Fc fusion construct, in
which codon optimized JRFL gp120 was fused to Fc. The
expression vector for the soluble S1 unit of the SARS-CoV S
protein has been described previously (Hofmann et al., 2005).
The glycoprotein expression plasmids employed for the
generation of pseudotyped viruses have been described
previously (Simmons et al., 2003). All PCR amplified
sequences were confirmed by automated sequence analysis.
Expression analysis by flow cytometry
To assess cell surface expression of the DC-SIGNR
variants, fluorescence activated cell sorting analysis (FACS)
was performed. Transiently transfected 293T cells were
harvested, washed and resuspended in ice-cold FACS buffer
(PBS with 3% FBS; 0.01% NaN3). Approximately 2  105
cells were incubated with MAb anti-DCS 120526 (Jameson
et al., 2002) at 10 Ag/ml for 45 min on ice. Cells were
washed and incubated with phycoerythrin-conjugated anti-
mouse IgG (Vector, Burlingame, USA) at a final concentra-
tion of 10 Ag/ml for 45 min on ice. Thereafter, the cells
were washed, reconstituted in FACS buffer and analyzed by
FACS employing a FACSCalibur flow cytometer (Becton
Dickinson).
Binding of soluble viral glycoproteins to DC-SIGNR expressing
cells
Soluble EBOV-GP-Ig, SARS-CoV-S-Ig or control-Ig were
obtained by harvesting the supernatant of 293T cells 48
h after transient transfection with the respective expression
vectors. The supernatants containing the fusion proteins were
concentrated using Centricon Plus-20 centrifugal filters
(Millipore, USA). To measure binding to DC-SIGNR
variants, comparable amounts of soluble protein, as judged
by Western blot, were incubated with transiently transfected
293T cells for 45 min on ice. After washing with FACS
buffer, cells were stained with Cyan5-conjugated anti-human
IgG (Jackson ImmunoResearch, USA) at a final concentra-
tion of 15 Ag/ml for 45 min on ice. Cells were then washed
and diluted in FACS buffer, binding was measured by flow-
cytometry using a FACS Calibur flow cytometer (Becton
Dickinson).
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DC-SIGNR-mediated enhancement of infection
EBOV-GP, SARS-CoV-S or VSV-G bearing lentiviral
pseudotypes and replication competent HIV-1 NL4-3 luciferase
reporter virus (NL4-3 Luc) were generated as described
elsewhere (Hofmann et al., 2004; Po¨hlmann et al., 2001a;
Simmons et al., 2003). In brief, 293T cells were transiently
cotransfected with pNL4-3 ER Luc (Connor et al., 1995)
and an expression plasmid for EBOV-GP, SARS-CoV-S or
VSV-G or transfected with NL4-3 Luc using the calcium
phosphate method. The culture medium was replaced after 16
h and harvested 48 h post-transfection. The supernatants were
passed through 0.4 Am filters and stored at 80 -C. To analyze
the impact of DC-SIGNR expression on EBOV-GP, SARS-
CoV-S or VSV-G driven infection, the indicated cell lines were
seeded in 96-well plates and infected with the indicated
pseudotypes. After overnight incubation, the infection medium
was replenished and cells cultivated for 3 days before cells
were lysed and luciferase activities determined using a
commercially available kit (Promega, Madison, USA). Transfer
of HIV-1 NL4-3 Luc by the different DC-SIGNR isoforms was
assessed in a cocultivation assay. 293T cells were transiently
transfected with the DC-SIGNR variants. After 48 h, cells were
transferred in eppendorf tubes and incubated with 3 ng of
luciferase reporter virus for 3 h at 37 -C. Thereafter, cells were
washed with fresh RPMI medium and cocultivated with
CEMx174 5.25 target cells in 96-well dishes. Three days after
cocultivation, cells were lysed and luciferase activities deter-
mined as described above.
Western blot analysis of lectin multimerization
293T cells transiently expressing the indicated DC-SIGNR
variants or control vector were lysed under reducing and non-
reducing conditions. For reducing conditions, samples were
dissolved in sodium dodecyl sulfate (SDS)-Laemmli buffer and
boiled for 15 min at 95 -C, whereas under non-reducing
conditions, cells were lysed in 10 mM Tris–HCl, 1 mM EDTA,
1 mM PMSF and 0.5% TritonX100 for 60 min on ice and
diluted in SDS-Laemmli buffer without h-mercaptoethanol.
Samples were separated via SDS gel-electrophoresis and
transferred onto nitrocellulose membranes (Schleicher and
Schuell, Dassel, Germany). The indicated lectins were detected
by staining with the MAb DCN46 at a concentration of 1 Ag/ml
(Geijtenbeek et al., 2000b) and 0.3 Ag/ml peroxidase-conju-
gated anti-mouse IgG (Jackson ImmunoResearch, USA).
Chemiluminescence detection was performed according to
the manufacturer’s protocol (ECL Western detection kit;
Amersham Pharmacia Biotech Europe, Freiburg, Germany).
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